ELOX insider transactions
Eloxx Pharmaceuticals Inc. (ELOX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for ELOX
- SEC Form 3 filed by new insider Webster Stephen W3 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 3 filed by new insider Kjellson Nina S3 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- Large owner Coastlands Capital Lp disposed of 1,250,000 shares (SEC Form 4)4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- Director Rubin Steven D converted options into 1,875 shares, increasing direct ownership by 15% to 14,625 units (SEC Form 4)4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- President and CEO Aggarwal Sumit exercised 472,826 shares at a strike of $0.08 and was granted 1,000,000 shares, increasing direct ownership by 737% to 1,672,756 units (SEC Form 4)4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- Director Walts Alan Edmund converted options into 1,875 shares, increasing direct ownership by 14% to 15,567 units (SEC Form 4)4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- New insider Domicilium Real Estate Fund Iii Lp claimed ownership of 1,407,138 shares (SEC Form 3)3 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- New insider Coastlands Capital Lp claimed ownership of 1,250,000 shares (SEC Form 3)3 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- Director Walts Alan Edmund was granted 12,000 shares, increasing direct ownership by 1,274% to 12,942 units (SEC Form 4)4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- Director Androski Lindsay was granted 12,000 shares (SEC Form 4)4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- Director Rubin Steven D was granted 12,000 shares (SEC Form 4)4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- PRESIDENT AND CEO Aggarwal Sumit was granted 165,000 shares, increasing direct ownership by 3,347% to 169,930 units (SEC Form 4)4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Walts Alan Edmund4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Rubin Steven D4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Androski Lindsay4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Aggarwal Sumit4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Walts Alan Edmund4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Rubin Steven D4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Kariv Tomer4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Androski Lindsay4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Aggarwal Sumit4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Modur Vijay4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Androski Lindsay4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 3 filed by new insider Androski Lindsay3 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Walts Alan Edmund4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Veinrib Gadi4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Seehra Jasbir4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Rubin Steven D4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Parekh Rajesh B4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Nussbaum Ran4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Kariv Tomer4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Avnur Zafrira4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4: Walts Alan Edmund converted options into 37,695 shares4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4: Aggarwal Sumit covered exercise/tax liability with 81,933 shares and converted options into 279,158 shares4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4: Modur Vijay converted options into 219,326 shares and covered exercise/tax liability with 64,373 shares4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4: Geffken Daniel E. bought $36,000 worth of shares (50,000 units at $0.72)4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4: Belloff Neil S. converted options into 1,563 units of Common Stock and covered exercise/tax liability with 459 units of Common Stock, increasing direct ownership by 3% to 32,699 units4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4: Belloff Neil S. exercised 6,250 units of Common Stock at a strike of $0.00 and covered exercise/tax liability with 1,835 units of Common Stock, increasing direct ownership by 16% to 31,595 units4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Walts Alan Edmund4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Nussbaum Ran4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Avnur Zafrira4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Seehra Jasbir4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4: PAREKH RAJESH B bought $3,329,999 worth of Common Stock (2,466,666 units at $1.35)4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4: Pontifax Management 4 G.P. (2015) Ltd. bought $7,999,999 worth of Common Stock (5,925,925 units at $1.35)4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4: Nussbaum Ran bought $7,999,999 worth of Common Stock (5,925,925 units at $1.35)4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4: Kariv Tomer bought $7,999,999 worth of Common Stock (5,925,925 units at $1.35)4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4: Belloff Neil S. exercised 1,562 units of Common Stock at a strike of $0.00 and disposed of $1,001 worth of Common Stock (459 units at $2.18), increasing direct ownership by 4% to 27,180 units4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Geffken Daniel E.4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4: B Rajesh Parekh was granted 2,532,270 units of Common Stock4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 3 filed by B Rajesh Parekh3 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 3 filed by Vijay Modur3 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Edmund Alan Walts4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 3 filed by E. Daniel Geffken3 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Vijay Modur4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4 filed by Sumit Aggarwal4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 3 filed by Sumit Aggarwal3 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 3 filed by Edmund Alan Walts3 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 3 filed by D. Gary Rakers3 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4: S. Neil Belloff exercised 25,000 units of Common Stock at a strike of $0.00 and disposed of $28,985 worth of Common Stock (7,338 units at $3.95), increasing ownership by 210% to 26,077 units4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
- SEC Form 4: C. Gregory Williams exercised 50,000 units of Common Stock at a strike of $0.00 and disposed of $60,672 worth of Common Stock (15,360 units at $3.95), increasing ownership by 347% to 44,629 units4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)